4198
欣大健康
+0.10 (+0.20%)49.903成交張數–本益比5.90股價淨值比0.00%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入2025204年增 -15.0%
毛利率202532.9%最新一期
營業利益率2025-22.8%最新一期
每股盈餘2025-1.96
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | +1.4% | -30.3% | -43.8% | -44.2% | +20.7% | +108.0% | +0.0% | -5.6% | -15.0% | |
| 營業成本合計 | – | +1.3% | -35.1% | -41.6% | -25.3% | +4.4% | +65.8% | +1.3% | -24.5% | -17.0% | |
| 營業毛利（毛損） | – | +2.9% | +63.0% | -60.6% | -260.2% | – | – | -7.1% | +110.4% | -10.5% | |
| 營業毛利（毛損）淨額 | – | +2.9% | +63.0% | -60.6% | -260.2% | – | – | -7.1% | +110.4% | -10.5% | |
| 推銷費用 | – | +4.9% | -46.2% | -53.4% | -60.0% | -2.3% | +171.8% | -4.9% | +39.9% | -25.4% | |
| 管理費用 | – | -22.4% | -19.3% | -52.3% | -17.3% | -2.6% | +24.6% | +0.3% | +6.1% | -17.3% | |
| 研究發展費用 | – | -37.7% | -51.3% | -17.7% | +5.0% | -32.7% | -12.1% | -29.3% | -33.5% | -11.5% | |
| 預期信用減損損失（利益） | – | – | – | – | – | -143.6% | – | -88.5% | -127.9% | – | |
| 營業費用合計 | – | -18.0% | -36.6% | -49.6% | -20.1% | -14.1% | +56.2% | -13.7% | +11.2% | -20.5% | |
| 營業利益（損失） | – | – | – | – | – | – | – | – | – | – | |
| 利息收入 | – | – | – | – | – | -42.5% | -26.1% | +398.3% | +89.7% | -10.2% | |
| 其他收入 | – | -53.0% | +109.0% | -56.0% | +337.3% | -48.4% | +193.1% | -50.5% | -80.0% | -37.6% | |
| 其他利益及損失淨額 | – | – | – | – | – | – | – | – | -89.5% | -102.7% | |
| 財務成本淨額 | – | -2.7% | -19.8% | +51.2% | -7.8% | -9.8% | +36.5% | +121.3% | -58.6% | -52.5% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | -100.0% | – | – | – | – | – | – | – | – | |
| 營業外收入及支出合計 | – | – | – | – | – | -59.7% | +408.7% | +387.6% | -88.9% | -108.7% | |
| 稅前淨利（淨損） | – | – | – | – | – | – | – | – | -145.0% | – | |
| 所得稅費用（利益）合計 | – | 0.0% | -33.5% | -39.3% | -49.5% | -100.0% | – | – | – | -123.6% | |
| 繼續營業單位本期淨利（淨損） | – | – | – | – | – | – | – | – | -147.1% | – | |
| 本期淨利（淨損） | – | – | – | – | – | – | – | – | -147.1% | – | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | -19.9% | -140.0% | – | – | +20.0% | -33.3% | +200.0% | |
| 不重分類至損益之項目： | – | – | – | – | -114.3% | – | – | +20.0% | -33.3% | +200.0% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | – | +408.3% | -231.6% | – | -322.0% | – | – | – | |
| 後續可能重分類至損益之項目： | – | – | – | – | -231.6% | – | -322.0% | – | – | – | |
| 其他綜合損益（淨額） | – | -131.8% | – | -32.0% | -138.5% | – | -968.1% | – | -25.5% | +775.0% | |
| 本期綜合損益總額 | – | – | – | – | – | – | – | – | -145.0% | – | |
| 母公司業主（淨利∕損） | – | – | – | – | – | – | – | – | -139.8% | – | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | – | – | – | – | |
| 母公司業主（綜合損益） | – | – | – | – | – | – | – | – | -137.8% | – | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | – | – | – | – | |
| 繼續營業單位淨利（淨損） | – | – | – | – | – | – | – | – | – | – | |
| 基本每股盈餘 | – | – | – | – | – | – | – | – | -138.1% | – | |
| 稀釋每股盈餘 | – | – | – | – | – | – | – | – | – | – | |
| 確定福利計畫之再衡量數 | – | -29.7% | -30.0% | -52.6% | -100.0% | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | – | – | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。